Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
04/2012
04/12/2012US20120087900 Immunotherapeutic agent
04/12/2012US20120087870 Novel caviidae allergens and uses thereof
04/12/2012US20120087861 Human Anti-Tau Antibodies
04/12/2012US20120087858 Dual variable domain immunoglobulins and uses thereof
04/12/2012CA2812392A1 Macaca fascicularis ccl17
04/12/2012CA2812389A1 Antibodies binding human collagen ii
04/12/2012CA2811087A1 Antibody compositions and methods of use
04/11/2012EP2439273A2 Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
04/11/2012EP2439272A2 Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
04/11/2012EP2439269A1 Expression vector for establishing hyper-producing cells, and hyper-producing cells
04/11/2012EP2438185A1 Methods of modulating fucosylation of glycoproteins
04/11/2012EP2438171A1 Fucosylation-deficient cells
04/11/2012EP2438090A1 Amino acid sequences which enhance peptide conjugate solubility
04/11/2012EP2437869A2 Multiplex analysis of stacked transgenic protein
04/11/2012EP2437780A1 Therapeutic compositions and methods for the prevention of autoimmune diseases
04/11/2012EP2437779A1 Reagents and methods for detecting influenza virus proteins
04/11/2012EP2067857B1 Method for production of dipeptide
04/11/2012EP2025749B1 Humanized anti-human osteopontin antibody
04/11/2012EP1969175B1 A novel catalytic reactor process for the production of commercial grade pulp, native lignin and unicellular protein
04/11/2012EP1907412B1 Peptides inhibiting angiotensin-converting enzyme
04/11/2012EP1631316B1 Targeted biocides
04/11/2012EP1594533B1 Antibody vaccine conjugates and uses therefor
04/11/2012EP1541680B9 Cytotoxic antibody against a c-terminal peptide of gpc3
04/11/2012EP1334120B1 Modified clostridial neurotoxins with altered biological persistence
04/11/2012EP1282646B1 Human monoclonal antibodies to dendritic cells
04/11/2012EP1125947B1 Human H37 protein and cDNA encoding the same
04/11/2012EP0931162B1 Production of a multimeric protein by cell fusion method
04/11/2012CN1984926B Fsh糖基化突变体 Fsh glycosylation mutants
04/11/2012CN102414323A 用于生产感兴趣的重组多肽的方法 Methods for recombinant production of the polypeptide of interest
04/11/2012CN102414319A Protein-type electron mediator
04/11/2012CN102414218A Tag peptide having protease recognition sequence and utilization of same
04/11/2012CN102409072A Method for preparing composite blood pressure lowering peptide by using marine organism
04/11/2012CN102407085A 采用酶法水解制革下脚料为原料制备表面活性剂的方法 Enzymatic hydrolysis of tannery waste as raw material preparation method of surfactant
04/11/2012CN102406944A 抗ku70内化的抗体 Within the anti-ku70 antibodies
04/11/2012CN101374948B Variant humicola grisea CBH1.1
04/11/2012CN101309932B 新粘蛋白型糖蛋白及其应用 New mucin-type glycoprotein and its applications
04/11/2012CN101296938B 粘菌素原料粉末的制造方法 The method of producing a raw material powder colistin
04/10/2012US8153775 Kits for detecting rank
04/10/2012US8153767 Antibody against aflatoxins, support using the antibody, method of immunologically detecting aflatoxins and method of concentrating and purifying aflatoxins
04/10/2012US8153765 Anti-CD38 antibodies for the treatment of cancer
04/10/2012US8153762 Composition for palladium-mediated cleavage of peptides containing CXC, CXH or CHM sequences
04/10/2012US8153428 Use of TGF beta superfamily antagonists and neurotrophins to make neurons from embryonic stem cells
04/10/2012US8153411 Dehalogenases, nucleic acids encoding them and methods for making and using them
04/10/2012US8153402 Emulsion compositions
04/10/2012US8153399 Methods and compositions for inactivating glutamine synthetase gene expression
04/10/2012US8153398 Polynucleotides encoding signal peptide-containing molecules
04/10/2012US8153397 Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
04/10/2012US8153396 Method for producing a casein hydrolysate
04/10/2012US8153395 Method of making activated carboxypeptidases
04/10/2012US8153391 Hydrolases, nucleic acids encoding them and methods for making and using them
04/10/2012US8153364 Emulsion compositions
04/10/2012US8153358 selection and enrichment occurs in aqueous droplets formed in an emulsion that compartmentalize individual polynucleotides from the library or a plurality of polynucleotides that may include polynucleotides not derived from the library, transcription and translation reagents
04/10/2012US8153134 Anti-MDL-1 antibodies
04/10/2012US8153133 High potency recombinant antibodies and method for producing them
04/10/2012US8153132 Antibodies immunoreactive with mutant hydroxypenylpyruvate dioxygenase
04/10/2012US8153124 Method for treating cancer using monoclonal antibodies
04/10/2012US8153119 Engineered enzymatically active bacteriophage and methods for dispersing biofilms
04/10/2012CA2598893C Eml4-alk fusion gene
04/10/2012CA2534349C Human skin equivalents expressing exogenous polypeptides
04/10/2012CA2445253C Single chain camelid vhh antibodies, method for their production in a mammal, and their uses
04/10/2012CA2438921C Streptococcus pyogenes polypeptides and corresponding dna fragments
04/10/2012CA2432329C Lipase variants
04/10/2012CA2412035C Hcv antigen/antibody combination assay
04/10/2012CA2401032C Memno peptides, a process for their preparation and their use
04/10/2012CA2395713C G-csf conjugates
04/10/2012CA2385325C Chlamydia antigens and corresponding dna fragments and uses thereof
04/10/2012CA2360511C Methods for generating phosphorylation site-specific immunological reagents
04/10/2012CA2353086C Pgc-1, a novel brown fat ppar.gamma. coactivator
04/05/2012WO2012045082A2 Engineered nucleic acids and methods of use thereof
04/05/2012WO2012043755A1 Cis-acting element and utilization thereof
04/05/2012WO2012043634A1 Antibody against human prostaglandin e2 receptor ep4
04/05/2012WO2012042037A1 Polypeptides having endopeptidase activity and polynucleotides encoding same
04/05/2012WO2012041220A1 Method for purifying cyclic lipopeptide or salt thereof
04/05/2012WO2012041100A1 Method for producing nisin by fermentation
04/05/2012WO2012040980A1 Bacillus barbaricus strain scsio 02429 derived from sea and method for preparing small squid peptide using the same
04/05/2012WO2012040833A1 Simplifying residue relationships in protein design
04/05/2012WO2012009544A3 Domain insertion immunoglobulin
04/05/2012WO2011153380A3 Humanized monoclonal antibodies and methods of use
04/05/2012WO2011105841A3 Recombinant expression vector for expressing brazzein, and novel multiple mutation brazzein variant having greater sweetness
04/05/2012US20120084871 Npc1l1 orthologues
04/05/2012US20120083588 Neutral amino acid transporter and gene thereof
04/05/2012US20120083445 Compositions Containing HC-HA Complex and Methods of Use Thereof
04/05/2012US20120083442 Myostatin binding agents
04/05/2012US20120083428 Method and Device for Protein Delivery into Cells
04/05/2012US20120083426 Method
04/05/2012US20120083015 Antibodies against human tweak and uses thereof
04/05/2012US20120083014 Nicotiana Benthamiana Plants Deficient in Xylosyltransferase Activity
04/05/2012US20120083013 Glucosyltransferase specific to position-4 of furofuran-type lignan, and polynucleotide encoding same
04/05/2012US20120082996 Il-21 variants
04/05/2012US20120082696 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
04/05/2012US20120082693 Use of proteins and peptides encoded by the genome of a novel sars-associated coronavirus strain
04/05/2012US20120082681 Anti-il12rbeta1 antibodies and their use in treating autoimmune and inflammatory disorders
04/05/2012US20120082679 Antagonists of pcsk9
04/05/2012US20120082674 Enterococcus antigens
04/05/2012US20120082673 Human cytokine receptor
04/05/2012US20120082670 Cd33 binding agents
04/05/2012US20120082666 Antibody compositions and methods of use
04/05/2012US20120082644 Cytokines and neuroantigens for treatment of immune disorders
04/05/2012US20120082622 Macaca fascicularis CCL17
04/05/2012CA2821992A1 Engineered nucleic acids and methods of use thereof
1 ... 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 ... 1125